These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20923712)

  • 41. P300 auditory event-related potentials and neuropsychological study during donepezil treatment in vascular dementia.
    Paci C; Gobbato R; Carboni T; Sanguigni S; Santone A; Curatola L
    Neurol Sci; 2006 Feb; 26(6):435-7. PubMed ID: 16601937
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Positive effects of cerebrolysin on electroencephalogram slowing, cognition and clinical outcome in patients with postacute traumatic brain injury: an exploratory study.
    Alvarez XA; Sampedro C; Pérez P; Laredo M; Couceiro V; Hernández A; Figueroa J; Varela M; Arias D; Corzo L; Zas R; Lombardi V; Fernández-Novoa L; Pichel V; Cacabelos R; Windisch M; Aleixandre M; Moessler H
    Int Clin Psychopharmacol; 2003 Sep; 18(5):271-8. PubMed ID: 12920387
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Mild forms of multi-infarct dementia: effectiveness of cerebrolysin].
    Vereshchagin NV; Nekrasova EM; Lebedeva NV; Suslina ZA; Solov'ev OI; Piradov MA; Altunina MN
    Sov Med; 1991; (11):6-8. PubMed ID: 1767322
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cessation versus continuation of galantamine treatment after 12 months of therapy in patients with Alzheimer's disease: a randomized, double blind, placebo controlled withdrawal trial.
    Scarpini E; Bruno G; Zappalà G; Adami M; Richarz U; Gaudig M; Jacobs A; Schäuble B
    J Alzheimers Dis; 2011; 26(2):211-20. PubMed ID: 21606568
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The influence of cerebrolysin on the efficiency of subsequent therapy with amiridine++ in Alzheimer's disease patients (neuropsychological investigation)].
    Roshchina IF; Kolykhalov IV; Selezneva ND; Zharikov GA; Gerasimov NP; Gavrilova SI
    Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(12):43-6. PubMed ID: 10629930
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuroprotective treatment with cerebrolysin in patients with acute stroke: a randomised controlled trial.
    Ladurner G; Kalvach P; Moessler H;
    J Neural Transm (Vienna); 2005 Mar; 112(3):415-28. PubMed ID: 15583955
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease.
    Burns A; Gauthier S; Perdomo C
    Int J Geriatr Psychiatry; 2007 Aug; 22(8):806-12. PubMed ID: 17199235
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluating rivastigmine in mild-to-moderate Parkinson's disease dementia using ADAS-cog items.
    Schmitt FA; Aarsland D; Brønnick KS; Meng X; Tekin S; Olin JT
    Am J Alzheimers Dis Other Demen; 2010 Aug; 25(5):407-13. PubMed ID: 20392860
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cerebrolysin in Alzheimer's disease.
    Antón Álvarez X; Fuentes P
    Drugs Today (Barc); 2011 Jul; 47(7):487-513. PubMed ID: 22013558
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rationale and design of a multicenter, phase 2 clinical trial to investigate the efficacy of traditional Chinese medicine SaiLuoTong in vascular dementia.
    Liang J; Li F; Wei C; Song H; Wu L; Tang Y; Jia J
    J Stroke Cerebrovasc Dis; 2014; 23(10):2626-2634. PubMed ID: 25294055
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Meta-analysis: the efficacy of nootropic agent Cerebrolysin in the treatment of Alzheimer's disease.
    Wei ZH; He QB; Wang H; Su BH; Chen HZ
    J Neural Transm (Vienna); 2007; 114(5):629-34. PubMed ID: 17318304
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial.
    Doody RS; Ferris SH; Salloway S; Sun Y; Goldman R; Watkins WE; Xu Y; Murthy AK
    Neurology; 2009 May; 72(18):1555-61. PubMed ID: 19176895
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials.
    Passmore AP; Bayer AJ; Steinhagen-Thiessen E
    J Neurol Sci; 2005 Mar; 229-230():141-6. PubMed ID: 15760632
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of the peptidergic nootropic drug cerebrolysin in patients with senile dementia of the Alzheimer type (SDAT).
    Rüther E; Ritter R; Apecechea M; Freytag S; Windisch M
    Pharmacopsychiatry; 1994 Jan; 27(1):32-40. PubMed ID: 8159781
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Spotlight on cerebrolysin in dementia.
    Plosker GL; Gauthier S
    CNS Drugs; 2010 Mar; 24(3):263-6. PubMed ID: 20155999
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Propentofylline in adult-onset cognitive disorders: double-blind, placebo-controlled, clinical, psychometric and brain mapping studies.
    Saletu B; Möller HJ; Grünberger J; Deutsch H; Rössner M
    Neuropsychobiology; 1990-1991; 24(4):173-84. PubMed ID: 2135708
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical correlates of cognitive decline in vascular dementia.
    Paul RH; Cohen RA; Moser DJ; Ott BR; Sethi M; Sweet L; Browndyke J; Malloy P; Garrett K
    Cogn Behav Neurol; 2003 Mar; 16(1):40-6. PubMed ID: 14765000
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and safety of cerebrolysin in neurorecovery after moderate-severe traumatic brain injury: results from the CAPTAIN II trial.
    Muresanu DF; Florian S; Hömberg V; Matula C; von Steinbüchel N; Vos PE; von Wild K; Birle C; Muresanu I; Slavoaca D; Rosu OV; Strilciuc S; Vester J
    Neurol Sci; 2020 May; 41(5):1171-1181. PubMed ID: 31897941
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improved global function and activities of daily living in patients with AD: a placebo-controlled clinical study with the neurotrophic agent Cerebrolysin.
    Muresanu DF; Rainer M; Moessler H
    J Neural Transm Suppl; 2002; (62):277-85. PubMed ID: 12456070
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The serial position effect in mild and moderately severe vascular dementia.
    Paul RH; Cohen RA; Moser DJ; Zawacki TM; Gordon N
    J Int Neuropsychol Soc; 2002 May; 8(4):584-7. PubMed ID: 12030311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.